stocks
ENNATURE

Ennature Bio Pharma Ltd.

178.40-17.4 (-8.86%)
19 Nov, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

0.0 / 100

Price Momentum Score

7.9 / 100

QVM Score

Score not available

Key Metrics

Market Cap
398.58
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Ennature Bio Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

178.40-17.4 (-8.86%)
-29.12% since 04 Nov 2026
1 Week returns: -14.80 %
Low
175.5
High
217.0
1 Month returns: –
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Ennature Bio Pharma Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Weak price momentum

Price Momentum score of 7.9 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

7.9 / 100

Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Ennature Bio Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Ennature Bio Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Ennature Bio Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

We currently lack sufficient shareholding data for this stock.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Ennature Bio Pharma Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of Ennature Bio Pharma Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Incorporated on
-
Last Annual
-
Last Interim
-
No. of Employees
-
IPO date
-
Free Float
-
Address
-

Frequently Asked Questions

What is the current share price of Ennature Bio Pharma Ltd.?
The current share price of Ennature Bio Pharma Ltd. is ₹ 178.40 as of 19 Nov 2026.
What is the market capitalisation of Ennature Bio Pharma Ltd.?
The market capitalisation of Ennature Bio Pharma Ltd. stands at ₹ 398.58 Cr.
What is the PE ratio of Ennature Bio Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Ennature Bio Pharma Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Ennature Bio Pharma Ltd.?
Ennature Bio Pharma Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Ennature Bio Pharma Ltd.?
The 52-week high of Ennature Bio Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Ennature Bio Pharma Ltd.?
The dividend yield of Ennature Bio Pharma Ltd. is - based on the current market price.
What is the FII and DII holding in Ennature Bio Pharma Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Ennature Bio Pharma Ltd. shares.
What sector does Ennature Bio Pharma Ltd. belong to?
Ennature Bio Pharma Ltd. operates in the Healthcare sector.
What is the beta of Ennature Bio Pharma Ltd.?
The beta of Ennature Bio Pharma Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Ennature Bio Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Ennature Bio Pharma Ltd. is -. An RSI above 70 is considered overbought and below 30 is considered oversold.